HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

NCT04618367 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular
Liver Neoplasms
Sintilimab
Portal Vein Tumor Thrombus

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Lenvatinib
DRUG: Sintilimab

Sponsor

Sun Yat-sen University

Collaborators

[object Object]